ARCHIVES

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

This article is from The Cancer Letter archive.

Vol. 25 No. 46 | December 3, 1999

Download PDF Visit The Full Archive

Related Articles

Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards

October 28, 1983

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994